Evidence map›Paper›PMID 39261923›Full record

ArticleDiabetology & metabolic syndrome2024

Effects of glycaemic control on memory performance, hippocampal volumes and depressive symptomology.

Gulin Yatagan Sevim, Erkan Alkan, Tamara P Taporoski, Jose E Krieger, Alex C Pereira, Simon L Evans

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gulin Yatagan SevimFaculty of Health and Medical Sciences, School of Psychology, University of Surrey, Guildford, Surrey, GU2 7XH, UK.
Erkan AlkanFaculty of Health, Science, Social Care and Education, Kingston University, London, UK.
Tamara P TaporoskiHarvard Center for Population and Development Studies, Harvard University, Cambridge, Massachusetts, USA.
Jose E KriegerUniversity of São Paulo School of Medicine, São Paulo, Brazil.
Alex C PereiraUniversity of São Paulo School of Medicine, São Paulo, Brazil.
Simon L EvansFaculty of Health and Medical Sciences, School of Psychology, University of Surrey, Guildford, Surrey, GU2 7XH, UK. se0016@surrey.ac.uk.

Funding

Fundação de Amparo a Pesquisa do Estado de São Paulo FAPESP, 2013/17368-0
6 · The paper itself

Abstract

backgroundDiabetes and poor glycaemic control have been shown to negatively impact cognitive abilities, while also raising risk of both mood disorders and brain structural atrophy. Sites of atrophy include the hippocampus, which has been implicated in both memory performance and depression. The current study set out to better characterise the associations between poor glycaemic control, memory performance, and depression symptoms, and investigate whether loss of hippocampal volume could represent a neuropathological mechanism underlying these.

methods1331 participants (60.9% female, age range 18-88 (Mean = 44.02), 6.5% with likely diabetes) provided HbA1c data (as an index of glycaemic control), completed a word list learning task, and a validated depression scale. A subsample of 392 participants underwent structural MRI; hippocampal volumes were extracted using FreeSurfer.

resultsPartial correlation analyses (controlling for age, gender, and education) showed that, in the full sample, poorer glycaemic control was related to lower word list memory performance. In the MRI sub-sample, poorer glycaemic control was related to higher depressive symptoms, and lower hippocampal volumes. Total hippocampus volume partially mediated the association between HbA1c levels and depressive symptoms.

conclusionsResults emphasise the impact of glycaemic control on memory, depression and hippocampal volume and suggest hippocampal volume loss could be a pathophysiological mechanism underlying the link between HbA1c and depression risk; inflammatory and stress-hormone related processes might have a role in this.

Indexed as

DepressionDepressive symptomsDiabetesGlycated haemoglobinHbA1cHippocampal volumeHippocampusMemoryMental healthMRI

Identifiers

PMID39261923
PMCPMC11389280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.